CRC
REGN icon

Curi RMB Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Curi RMB Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41M Sell
1,820
-20
-1% -$15.3K 0.03% 389
2025
Q4 		$1.42M Buy
+1,840
New +$1.25M 0.02% 398
2019
Q3 		– Sell
-663
Closed -$208K – 777
2019
Q2 		$208K Sell
663
-117
-15% -$39K 0.01% 697
2019
Q1 		$320K Buy
780
+62
+9% +$25.5K 0.01% 659
2018
Q4 		$268K Hold
718
– – 0.01% 766
2018
Q3 		$290K Sell
718
-205
-22% -$78K 0.01% 739
2018
Q2 		$318K Buy
923
+10
+1% +$3.13K 0.01% 713
2018
Q1 		$314K Sell
913
-441
-33% -$153K 0.01% 714
2017
Q4 		$509K Buy
1,354
+431
+47% +$175K 0.01% 600
2017
Q3 		$413K Hold
923
– – 0.01% 553
2017
Q2 		$453K Buy
923
+100
+12% +$43.8K 0.01% 546
2017
Q1 		$319K Sell
823
-4,995
-86% -$1.85M 0.01% 437
2016
Q4 		$2.14M Buy
5,818
+300
+5% +$114K 0.11% 181
2016
Q3 		$2.22M Buy
+5,518
New +$2.21M 0.12% 185
2016
Q1 		– Sell
-518
Closed -$281K – 460
2015
Q4 		$281K Hold
518
– – 0.01% 353
2015
Q3 		$241K Hold
518
– – 0.02% 382
2015
Q2 		$264K Hold
518
– – 0.02% 367
2015
Q1 		$234K Hold
518
– – 0.01% 442
2014
Q4 		$213K Buy
+518
New +$204K 0.01% 414
2014
Q1 		– Sell
-875
Closed -$241K – 386
2013
Q4 		$241K Buy
875
+85
+11% +$24.4K 0.02% 317
2013
Q3 		$247K Buy
+790
New +$208K 0.02% 328

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Curi RMB Capital's REGN Position: Q1 2026 in Review

Curi RMB Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 1.1% in Q1 2026, selling an estimated $15.3K and leaving 1,820 shares worth $1.41M. The position accounts for 0.03% of the portfolio, ranked #389.

Curi RMB Capital first reported a position in REGN in Q3 2013 and has held it in 21 quarters since. The position peaked at $2.22M in Q3 2016. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Curi RMB Capital held 1,820 shares of Regeneron Pharmaceuticals worth $1.41M as of Q1 2026.
  • Curi RMB Capital sold 20 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $15.3K.
  • Regeneron Pharmaceuticals made up 0.03% of Curi RMB Capital's portfolio in Q1 2026, its #389 holding.
  • Curi RMB Capital first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 21 quarters since.
  • Curi RMB Capital's Regeneron Pharmaceuticals position peaked at $2.22M in Q3 2016.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.